Stocks
Cortexyme () Debt/EBITDA US GAAP (year values) |
|||||||||
| 2017 | 2018 | 2019 | 2020 | 2021 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 0.02 | 6.25 | 2.55 | 1.69 | 1.18 | 1.13 | |||
| Changes by years, y/y, % | +38 247% | -59% | -34% | -30% | +191.5% | ||||
Cortexyme. Debt/EBITDA
Cortexyme. Debt/EBITDA, changes, %
Cortexyme () Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2021Q2 | 2021Q3 | 2021Q4 | 2022Q1 | 2022Q2 | LTM ? | |||
| Debt/EBITDA | 1.51 | 1.34 | 1.18 | 1.02 | 1.13 | 1.13 | ||
| Changes by years, y/y, % | -38% | -31% | -32% | -43% | -25% | |||
| Changes by quarters, q/q, % | -16% | -12% | -12% | -13% | +11% | |||
